NCT03626922 2022-06-10Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer PatientsNSABP Foundation IncPhase 1 Unknown33 enrolled
NCT00554827 2020-01-03Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaAcrotech Biopharma Inc.Phase 1 Completed55 enrolled
NCT01134341 2019-12-18Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaAcrotech Biopharma Inc.Phase 1 Completed34 enrolled
NCT03101579 2019-03-19Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung CancerThe First Hospital of Jilin UniversityPhase 1 Completed13 enrolled